ANNAW
NASDAQ
$0.32
AleAnna Inc - Warrants (13/12/2029) (ANNAW)
AleAnna, Inc. Warrant (ANNAW) is an innovative biopharmaceutical firm focused on creating transformational therapies for significant unmet medical needs. The company's strategic development includes a strong pipeline of proprietary drug candidates, supported by advanced technologies and collaborative partnerships within the healthcare industry. AleAnna is well-positioned for successful commercialization of its therapeutics, offering institutional investors a promising opportunity for growth in the rapidly evolving biopharmaceutical landscape. With its commitment to enhancing patient outcomes, AleAnna is set to make a notable impact in the healthcare sector.
This company is also listed under the following ticker: ANNA.
Website: https://www.aleannainc.comBeta (5Y)
-1.23
Price Chart
Profitability
Total Revenue (TTM)$17M
EBITDA$2.36M
Profit Margin-47.1%
Operating Margin51%
Growth & Risk
Beta (5Y)-1.23
Sharpe Ratio1.19